Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-04-17

FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for COARTEM (artemether and lumefantrine) from Novartis Pharmaceuticals Corporation, representing an expansion/modificat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coartem (artemether-lumefantrine)

Snippet

SUPPL AP for COARTEM (ARTEMETHER AND LUMEFANTRINE)